We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$3.23B
AUM Growth
-$336M
Cap. Flow
-$364M
Cap. Flow %
-11.28%
Top 10 Hldgs %
18.06%
Holding
808
New
164
Increased
157
Reduced
273
Closed
96

Sector Composition

Rank Sector Weight
1 Industrials 20.92%
2 Consumer Discretionary 13.73%
3 Financials 13.33%
4 Technology 11.49%
5 Materials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAC icon
276
Marriott Vacations Worldwide
VAC
$3.95B
$1.48M 0.05%
+12,535
New +$1.41M
ETR icon
277
Entergy
ETR
$50B
$1.47M 0.05%
38,380
+32,380
+540% +$1.25M
PKOH icon
278
Park-Ohio Holdings
PKOH
$666M
$1.47M 0.05%
38,630
-23,390
-38% -$877K
CYD icon
279
China Yuchai International
CYD
$1.49B
$1.47M 0.05%
+80,490
New +$1.44M
TER icon
280
Teradyne
TER
$56.8B
$1.46M 0.05%
48,610
+43,610
+872% +$1.47M
AGNC icon
281
AGNC Investment
AGNC
$12.8B
$1.46M 0.05%
68,525
+61,100
+823% +$1.27M
AER icon
282
AerCap
AER
$23.6B
$1.46M 0.05%
31,365
+28,190
+888% +$1.27M
HCA icon
283
HCA Healthcare
HCA
$92.5B
$1.45M 0.05%
16,644
+14,094
+553% +$1.19M
CVGI icon
284
Commercial Vehicle Group
CVGI
$124M
$1.45M 0.04%
+171,250
New +$1.4M
M icon
285
Macy's
M
$6B
$1.45M 0.04%
62,270
+61,570
+8,796% +$1.58M
NIM icon
286
Nuveen Select Maturities Municipal Fund
NIM
$116M
$1.44M 0.04%
142,927
-15,720
-10% -$158K
JCAP
287
DELISTED
Jernigan Capital, Inc.
JCAP
$1.44M 0.04%
+65,550
New +$1.5M
HAS icon
288
Hasbro
HAS
$13.6B
$1.44M 0.04%
+12,925
New +$1.33M
NFG icon
289
National Fuel Gas
NFG
$7.94B
$1.44M 0.04%
25,786
+20,415
+380% +$1.15M
FNF icon
290
Fidelity National Financial
FNF
$12.7B
$1.44M 0.04%
+46,194
New +$1.33M
REX icon
291
REX American Resources
REX
$1.4B
$1.43M 0.04%
+89,040
New +$1.41M
AMAT icon
292
Applied Materials
AMAT
$381B
$1.43M 0.04%
34,570
+31,520
+1,033% +$1.34M
MTX icon
293
Minerals Technologies
MTX
$2.24B
$1.42M 0.04%
19,440
-7,060
-27% -$527K
BGC icon
294
BGC Group
BGC
$5.66B
$1.42M 0.04%
+174,471
New +$1.31M
VIAB
295
DELISTED
Viacom Inc. Class B
VIAB
$1.41M 0.04%
+42,120
New +$1.6M
CPA icon
296
Copa Holdings
CPA
$5.99B
$1.41M 0.04%
+12,035
New +$1.39M
ESNT icon
297
Essent Group
ESNT
$6.25B
$1.41M 0.04%
37,880
+33,905
+853% +$1.25M
KBAL
298
DELISTED
Kimball International
KBAL
$1.41M 0.04%
+84,180
New +$1.46M
CBT icon
299
Cabot Corp
CBT
$4.37B
$1.4M 0.04%
26,242
+21,169
+417% +$1.16M
HRC
300
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.4M 0.04%
+17,600
New +$1.33M

Similar funds

James Investment Research's Q2 2017 Portfolio in Review

As of Q2 2017, James Investment Research held 808 positions worth $3.23B, down 9.4% from $3.56B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

James Investment Research withdrew a net $364M in Q2 2017, closing 96 positions and reducing 273 holdings. Its most notable exit was Devon Energy, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, James Investment Research opened a new position in Carnival Corporation Ltd worth $11.1M.

  • James Investment Research's largest Q2 2017 buy was Carnival Corporation Ltd: 169,648 shares worth $11.1M.
  • James Investment Research added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2017, an estimated $27.9M increase.
  • James Investment Research's biggest Q2 2017 reduction was Merck, cutting an estimated $33.1M.
  • James Investment Research fully exited Devon Energy in Q2 2017, selling an estimated $11.8M.
  • James Investment Research's ten largest holdings make up 18% of its $3.23B portfolio in Q2 2017.
  • James Investment Research opened 164 new positions and closed 96 in Q2 2017.
  • James Investment Research's portfolio value fell 9.4% quarter-over-quarter to $3.23B.

Based on James Investment Research's 13F filing for Q2 2017, filed 14 Jul 2017.